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Research
Several epidemiologic investigations have
demonstrated that ambient air pollution is
associated with increased risk of cardiovascular
disease (Brook et al. 2004). In particular, acute
increases in ambient particulate matter (PM)
levels have been associated with myocardial
infarction, stroke, and other adverse effects on
cardiovascular function (Biggeri et al. 2004;
Forastiere et al. 2005; Katsouyanni et al. 2001;
O’Neill et al. 2005; Samet et al. 2000b;
Schwartz et al. 2005; Wellenius et al. 2005;
Zanobetti and Schwartz 2005; Zanobetti et al.
2004). The mechanisms linking inhalation of
air pollutants to an increased cardiovascular
risk are not fully understood (Bhatnagar 2006;
Brook et al. 2002; Donaldson et al. 2001; Nel
2005; Peters et al. 1997, 2001). 
Epidemiologic investigations have
demonstrated that high plasma levels of total
homocysteine (tHcy) are an independent risk
factor for vascular disease, including coronary
artery, cerebrovascular, and peripheral occlu-
sive disease (Davey Smith and Ebrahim 2005;
Welch and Loscalzo 1998). In addition to
fasting tHcy measurements, tHcy determina-
tion after oral methionine load is used to
identify individuals with mild impairment of
Hcy metabolism, in whom fasting tHcy may
be normal but postmethionine-load (PML)
tHcy concentration is increased (Refsum et al.
2004). Alveolar and systemic inflammation
has been proposed as a central component in
the series of events linking the exposure to
inhaled pollutants to the observed increases in
cardiovascular morbidity and mortality
(Brook et al. 2004; Seaton et al. 1995).
Inflammation is a known determinant of
hyperhomocysteinemia (Gori et al. 2005; von
Eckardstein et al. 1994), and both air pollu-
tion and plasma tHcy have been associated
with increased levels of C-reactive protein, ﬁb-
rinogen, and interleukin-6 (Evans et al. 1997;
Ghio et al. 2003; Gori et al. 2005; Pekkanen
et al. 2000; Peters et al. 2001; Schwartz 2001;
Seaton et al. 1999; von Eckardstein et al.
1994). However, whether air pollution expo-
sure is correlated with increased tHcy levels
has never been determined. Gori et al. (2005)
suggested previously that short-term changes
in inflammatory markers are associated with
hyperhomocysteinemia when coupled with a
mild persistent inﬂammatory state. In healthy
subjects, tobacco smoking is a common cause
of persistent low-level inflammation, and
smoking has been also shown to induce ele-
vated tHcy levels (Bazzano et al. 2003;
De Bree et al. 2002; Guttormsen et al. 1996). 
In the present study, we investigate the
effects of air pollution levels on fasting and
PML tHcy in 1,213 normal subjects from
Lombardia, Italy. In addition, we examined
potential effect modification by cigarette
smoking of the relation between air pollution
and tHcy. 
Materials and Methods
Study population and laboratory methods.
From January 1995 to August 2005, 1,218
healthy individuals, who were partners or
friends of patients with thrombosis, attended
the Thrombosis Center of the University of
Milan, Italy, and agreed to undergo throm-
bophilia screening on a voluntary basis. Only
individuals resident in the Lombardia region
were chosen. Previous thrombosis was
excluded with a validated structured question-
naire (Frezzato et al. 1996). None of the sub-
jects was taking foline, vitamin B6, or vitamin
B12 supplements. All participants gave writ-
ten informed consent, and approval for the
study was obtained from the University of
Milan Departmental Institutional Review
Board.On the day of the visit, the participants
attended the Thrombosis Center at 0900 hr,
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BACKGROUND: Mild hyperhomocysteinemia is independently associated with an increased risk of
cardiovascular disease. Air pollution exposure induces short-term inﬂammatory changes that may
determine hyperhomocysteinemia, particularly in the presence of a preexisting proinflammatory
status such as that found in cigarette smokers. 
OBJECTIVE: We examined the relation of air pollution levels with fasting and postmethionine-load
total homocysteine (tHcy) in 1,213 normal subjects from Lombardia, Italy. 
METHODS: We obtained hourly concentrations of particulate matter < 10 µm in aerodynamic
diameter (PM10) and gaseous pollutants (carbon monoxide, nitrogen dioxide, sulfur dioxide,
ozone) from 53 monitoring sites covering the study area. We applied generalized additive models
to compute standardized regression coefﬁcients controlled for age, sex, body mass index, smoking,
alcohol, hormone use, temperature, day of the year, and long-term trends. 
RESULTS: The estimated difference in tHcy associated with an interquartile increase in average
PM10 concentrations in the 24 hr before the study was nonsignificant [0.4%; 95% confidence
interval (CI), –2.4 to 3.3 for fasting; and 1.1%, 95% CI, –1.5 to 3.7 for postmethionine-load
tHcy]. In smokers, 24-hr PM10 levels were associated with 6.3% (95% CI, 1.3 to 11.6; p < 0.05)
and 4.9% (95% CI, 0.5 to 9.6; p < 0.05) increases in fasting and postmethionine-load tHcy, respec-
tively, but no association was seen in nonsmokers (p-interaction = 0.005 for fasting and 0.039 for
postmethionine-load tHcy). Average 24-hr O3 concentrations were associated with signiﬁcant dif-
ferences in fasting tHcy (6.7%; 95% CI, 0.9 to 12.8; p < 0.05), but no consistent associations were
found when postmethionine-load tHcy and/or 7-day average O3 concentrations were considered. 
CONCLUSIONS: Air particles may interact with cigarette smoking and increase plasma homocysteine
in healthy subjects.
KEY WORDS: air pollution, cardiovascular risk, generalized additive models, homocysteine, particulate
matter, smoking. Environ Health Perspect 115:176–181 (2007). doi:10.1289/ehp.9517 available via
http://dx.doi.org/ [Online 13 November 2006]when a ﬁrst fasting blood sample was taken. A
standardized questionnaire was administered
including demographic data and questions on
education, occupation, smoking, alcohol con-
sumption, diet, reproductive history, and hor-
mone use (oral contraceptives or hormone
replacement therapy). Plasma tHcy was mea-
sured in EDTA anticoagulated blood samples,
as previously described (Martinelli et al.
2003). Blood was withdrawn after overnight
fasting for at least 8 hr, and again 4 hr afteran
oral methionine load (3.8 g/m2 body surface
area). Blood samples were immediately placed
on ice to prevent the artifactual in vitro
increase in plasma tHcy levels and centrifuged
at 1,600g at 4°C for 15 min within 1 hr. The
supernatant platelet-poor plasma was stored at
–80°C. Plasma tHcy was measured by high-
performance liquid chromatography and ﬂuo-
rescence detection (Zighetti et al. 1997). 
Air pollution and weather data. We
obtained from the Regional Environmental
Protection Agency (ARPA Lombardia) record-
ings of hourly air pollution data measured
from January 1994 to September 2005 by
monitors located at 53 different sites through-
out Lombardia (Figure 1A). The 53 stations
included in this study were selected by ARPA
Lombardia from the approximately 200 mon-
itors of the Regional Air Monitoring Network
on the basis of their location, reliability,
determined by standardized quality control
procedures and by correlation with in situ
measurements, and continuity of recording.
We identiﬁed nine different study areas in the
region (Figure 1A) characterized by homoge-
neous within-area air pollution concentra-
tions. Within each study area, levels of air
pollutants measured by different monitors
were highly correlated. The urban and subur-
ban Milan areas (areas 1 and 2) included
approximately 65% of the study subjects
(Baccarelli et al. 2006) and had between-
monitor correlations with r > 0.80 for all pol-
lutants. In the remaining areas, between
monitor correlations generally were > 0.70,
with a few exceptions. In particular, correla-
tions tended to be lower (r between 0.40–0.80)
in area 3, which comprises two cities
(Bergamo and Brescia) in a peculiar geo-
graphic location, partially enclosed in valleys
at the Alps foothills. Although our analyses on
pollution station data suggest that pollutant
levels were quite heterogeneous in area 3,
because only 18 subjects (1.5% of the total
study population) were residents of this area,
we did not modify the general strategy for
exposure assignment for this area. In addition,
mobile monitoring in each of the study areas
during the study period showed high concor-
dance with measurements taken by the perma-
nent monitors in the same area (ARPA
Lombardia 2006). For each study area, we
averaged mean hourly concentrations of PM
with an aerodynamic diameter ≤ 10 μm
(PM10), carbon monoxide, nitrogen dioxide,
sulphur dioxide, and ozone using an algorithm
that combined levels reported by multiple
monitoring locations (Schwartz 2000). We
used these average concentrations for exposure
assessment, after assigning each of the study
subjects to one of the nine pollution areas,
based on the subjects’ residence (Figure 1B).
The southern part of the Pavia province
(Figure 1A) was excluded, because this area
had no local monitoring stations and showed
pollution patterns in repeated point mobile
recordings that differed from those measured
by stationary monitors located in neighboring
areas. Most air pollution stations also obtained
data on weather, including air temperature,
relative humidity, barometric pressure, inten-
sity, and wind direction. We used data from
the nearest Regional Weather Service surface
station of the ARPA Lombardia network for
stations that did not measure metereologic
variables. In addition, we obtained data on
mean daily linear visibility recorded at the
three major airports (Milano Malpensa,
Milano Linate, Bergamo Orio al Serio), and at
one meteorologic station (Brescia-Ghedi)
available online from the U.S. National
Climatic Data Center (2006). 
We used linear visibility data to calculate
the extinction coefficient, which was shown
to be a good predictor of ﬁne particle concen-
trations (Ozkaynak et al. 1985). In most of
the areas, total suspended particles (TSPs)
rather than PM10 were measured in the earlier
years of the study period (1995 in area 4;
1995–1996 in area 3; 1995–1997 in areas 1
and 2; and 1995–1998 in areas 5, 6, 7, and
9). TSP measurements were continued in the
study areas after PM10 recording was intro-
duced. For the periods in which only TSP
measurements were available, we estimated
PM10 as the predicted value from a model
that included PM10 as the dependent variable
and, as independent variables, day of the
week, wind direction and penalized splines of
TSP, temperature, barometric pressure, rela-
tive humidity, wind intensity, extinction coef-
ficient, hour of the day, and date. The
penalized splines were used to allow for non-
linear associations with PM10 concentrations.
The analyses performed throughout this study
were done including the predicted data.
When predicted data were excluded from the
analyses, the point estimates obtained were
similar to those including predicted data, but
had wider conﬁdence intervals (CIs).
Statistical analysis. In the analysis of the
association of air pollutants with tHcy, the fol-
lowing variables were chosen a priori as rele-
vant predictors and included in the linear
regression analysis: age, sex, body mass index,
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Figure 1. Lombardia region maps reporting (A) the location of the 53 air pollution monitors in the nine air pollution homogenous areas identiﬁed for the study, and
(B) the residence of the study subjects. 
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We used penalized splines to account for
potential nonlinearity in the relationship of
day on the year [degrees of freedom (df) = 4],
long-term trend (df = 3), and temperature
(df = 4). The df of the penalized splines were
selected a priori. Temperature presents
U-shaped relations with several outcomes, and
4 dfs are sufficient to accommodate that. A
recent simulation study suggests that about
6 dfs per year were sufﬁcient to accommodate
the long-term trend and seasonal patterns in
mortality (Peng et al. 2006). We separated our
seasonal and long-term trend terms and given
that homocysteine is likely to have a less spiky
seasonal pattern than mortality data, we used
4 dfs to account for the seasonal pattern.
The dependent variables in the models
(fasting tHcy and PML tHcy) were log-trans-
formed to improve normality and stabilize the
variance. We performed regression analyses in
R software version 2.2.1 (R Project for
Statistical Computing, Vienna, Austria) using
generalized additive models to evaluate the rela-
tion of tHcy with each air pollutant. Effects are
expressed throughout the paper as percent dif-
ference in tHcy per interquartile range (IQR)
difference in air pollutant concentrations.
Results
The study included 488 (40.2%) male subjects
and 725 (59.8%) female subjects between 11
and 84 years of age (mean age = 43.5 years)
(Table 1). Only eight subjects were < 18 years
of age. Fasting plasma tHcy ranged between
2.9 and 59.6 μmol/L, with a mean concentra-
tion of 9.0 μmol/L (95% CI, 8.8–9.2). PML
tHcy ranged between 11.0 and 83.7 μmol/L,
with a mean concentration of 24.2 μmol/L
(95% CI, 23.8–24.6). Both fasting and PML
tHcy exhibited a positive association with
female sex, cigarette smoking, alcohol, and
body mass index (BMI) (Table 1). Older sub-
jects had higher fasting plasma tHcy, but PML
tHcy was not signiﬁcantly associated with age.
To evaluate possible confounding effects, we
generated linear regression models that
included sex, cigarette smoking, alcohol, BMI,
and age as independent variables. These
models showed an independent effect of sex
(p < 0.001 on fasting plasma tHcy; p < 0.001
on PML tHcy) and smoking (p = 0.03 on fast-
ing plasma tHcy; p = 0.002 on PML tHcy),
but no signiﬁcant associations were found for
age (p = 0.07 for fasting plasma tHcy; p = 0.19
for PML tHcy), alcohol (p = 0.30 for fasting
plasma tHcy; p = 0.92 for PML tHcy), or BMI
(p = 0.91 for fasting plasma tHcy; p = 0.49 for
PML tHcy)
We estimated air pollution exposure on the
basis of ambient measurements taken during
the study period. Air pollution levels and
weather variables in the study area from
1 January 1995 to 1 September 2005 are sum-
marized in Table 2.
Table 3 presents the estimated mean differ-
ences of fasting and PML tHcy associated with
an IQR increase in the average concentrations
of air pollutants in the 24 hr or in the 7 days
before the study. The estimates were adjusted
for age, sex, body mass index, cigarette smok-
ing, alcohol consumption, and hormone use.
In addition, penalized smoothing splines were
used in the models to adjust for nonlinear
effects of day of the year, long-term time trend,
and temperature. 
PM10 levels did not show a signiﬁcant asso-
ciations with fasting and PML tHcy. The esti-
mated increase in tHcy associated with the
average PM10 concentrations in the 24 hr
before the study was 0.4% (95% CI, –2.4 to
3.3) for fasting and 1.1% (95% CI, –1.5 to
3.7) for PML tHcy (differences were not statis-
tically signiﬁcant). Increases in 7-day PM10 lev-
els were associated with nonsigniﬁcant 1.0%
(95% CI, –1.5 to 3.7) and 2.0 (95% CI, –0.6
to 4.7) increases in fasting and PML tHcy,
respectively. Among the gaseous pollutants, the
average concentrations of O3 in the 24 hr
before the study were signiﬁcantly associated
with a 6.7% (95% CI, 0.9–12.8) increase in
fasting tHcy, but the association with PML
tHcy was not signiﬁcant (3.6%; 95% CI, –1.4
to 9.0). No association was found between the
7-day O3 average levels and fasting or PML
tHcy. Similarly, the other gaseous pollutants
were not associated with tHcy levels (Table 3).
We then evaluated the relation between air
pollution exposure, smoking, and plasma tHcy
levels. Among smokers, 24-hr PM10 levels were
associated with 6.3% (95% CI, 1.3–11.6; p <
0.05) and 4.9% (95% CI, 0.5–9.6; p < 0.05)
increases in fasting and PML tHcy, respectively
(Figure 2). In nonsmokers, the estimated dif-
ferences were –1.7% (95% CI, –4.8 to 1.5) for
fasting and –0.3 (95% CI, –3.1 to 2.6) for
PML tHcy. The tests for interaction between
PM10 and smoking were statistically signifi-
cant (p = 0.005 for fasting tHcy; p = 0.039 for
PML tHcy), whereas smoking in such models
was not associated per se with differences in
fasting (main effect = –5.9%; 95% CI –14.1
to 3.2; p = 0.20) or PML tHcy (main effect =
–0.6%; 95% CI –8.5 to 8.0; p = 0.89). The
association between the PM10 levels in the
7 days before the study and tHcy showed the
same pattern. For smokers, 7-day PM10 was
associated with a nonsignificant 3.3% (95%
CI, –1.5 to 8.4) increase in fasting tHcy and a
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Table 1. Fasting and postmethionine-load total homocysteine levels, by study subjects’ characteristics.
Fasting total  Postmethionine-load total 
homocysteine (µmol/l) homocysteine (µmol/L)
No. of subjects Mean (95% CI)a p-Valueb Mean(95% CI)a p-Valueb
All subjects 1,213 9.0 (8.8–9.2) — 24.2 (23.8–24.6) —
Age (years)
< 35 370 8.7 (8.4–9.1) 23.6 (22.8–24.3)
35–55 270 9.0 (8.6–9.4) 24.7 (23.8–25.7)
45–55 312 9.2 (8.8–9.5) 24.1 (23.4–24.8)
55–65 209 9.1 (8.7–9.5) 24.9 (23.9–25.9)
> 65 52 9.6 (8.9–10.4) 0.04 24.1 (22.5–25.8) 0.13
Sex
Male 488 10.4 (10.1–10.8) 25.8 (25.1–26.5)
Female 725 8.1 (8.0–8.3) < 0.001 23.1 (22.6–23.6) < 0.001
Smoking (cigarettes/day)
No 870 8.9 (8.7–9.1) 23.8 (23.4–24.3)
1–15 205 9.1 (8.6–9.6) 24.7 (23.6–25.8)
> 15 138 9.6 (9.1–10.2) 0.02 25.8 (24.5–27.3) 0.005
Alcohol
No 559 8.5 (8.3–8.8) 23.7 (23.1–24.3)
Yes 645 9.4 (9.2–9.7) < 0.001 24.6 (24.0–25.1) 0.04
Coffee (cups/day)
No 158 8.8 (8.3–9.2) 23.4 (22.3–24.6)
1 218 8.9 (8.5–9.4) 24.3 (23.3–25.4)
2 336 9.1 (8.8–9.5) 24.3 (23.6–25.1)
3 262 8.8 (8.4–9.1) 23.9 (23.1–24.8)
> 3 239 9.3 (8.9–9.7) 0.34 24.7 (23.7–25.6) 0.27
Body mass index (kg/m2)
< 21 285 8.4 (8.1–8.8) 23.3 (22.4–24.1)
21–23.5 326 8.9 (8.5–9.2) 24.3 (23.5–25.1)
23.5–26 295 9.0 (8.7–9.4) 23.9 (23.1–24.7)
> 26 301 9.7 (9.3–10.1) < 0.001 25.3 (24.4–26.2) 0.007
Hormone usec
No 527 8.1 (7.9–8.3) 22.9 (22.3–23.4)
Yes 167 8.1 (7.8–8.4) 0.84 23.5 (22.5–24.6) 0.25
aGeometric means are reported to account for lognormal tHcy distributions. bp-Value for trend across multiple categories
or Student’s t-test for differences between categories of binomial variables. cWomen who used oral contraceptives or
hormone replacement therapy at the time of blood sampling.signiﬁcant 5.2% (95% CI, 0.8 to 9.8; p < 0.05)
increase in PML tHcy. Although no signifi-
cant increase in tHcy was found among non-
smokers (0.1%, 95% CI, –3.2 to 3.3 for
fasting tHcy; 0.7%, 95% CI, –2.2 to 3.7 for
PML tHcy), the tests for interaction between
average 7-day PM10 and smoking were not
statistically significant (p = 0.23 for fasting
tHcy; p = 0.07 for PML tHcy). 
Our main results for PM10 exposure
reported above were based on analysis that
included both measured PM10 and predicted
PM10 values that were used for the earlier time
periods in which TSP rather than PM10 data
were available (see “Materials and Methods”).
The results based only on measured PM10 con-
ﬁrmed the presence of a statistical interaction
between PM10 and smoking. Among smokers,
measured 24-hr PM10 levels were associated
with 6.2% (95% CI, 0.0–12.7; p < 0.05) and
6.0% (95% CI, 0.5–11.8; p < 0.05) increases
in fasting and PML tHcy, respectively. In non-
smokers, the estimated differences were –1.6%
(95% CI, –5.5 to 2.5) for fasting and –0.1
(95% CI, –3.6 to 3.5) for PML tHcy. Again,
the tests for interaction between measured
PM10 and smoking were statistically signiﬁcant
(p = 0.026 for fasting tHcy; p = 0.048 for PML
tHcy). As for the main analysis based on both
measured and predicted PM10 levels, measured
mean PM10 levels in the 7 days before the
study were associated with higher tHcy in
smokers but not in nonsmokers, whereas the
interaction terms were again not statistically
signiﬁcant (data not shown). 
Gaseous pollutants (CO, NO2, SO2, and
O3) showed no significant interaction with
cigarette smoking in association with the
levels of fasting (p > 0.26) and PML tHcy
(p > 0.43). In addition, no signiﬁcant interac-
tion of the air pollutants evaluated with age,
sex, alcohol use, overweight (BMI > 25), and
obesity (BMI > 30). 
Discussion
In this study conducted on a large sample of
subjects from Lombardia, Italy, air pollution
levels measured in the week preceding the
study did not show overall consistent associa-
tions with fasting and PML tHcy. However,
we found that PM10 interacted with cigarette
smoking in determining increased tHcy levels.
PM10 levels, particularly those in the 24 hr
before the study, were associated with
increased fasting and PML tHcy in smokers
but not in nonsmokers. 
Tobacco smoking is one of the strongest
risk factors for cardiovascular disease. Previous
studies indicate that smoking is independently
associated with increased tHcy levels in
patients with coronary artery disease, ischemic
stroke, and diabetes as well as in the general
population (De Bree et al. 2002; Nygard et al.
1995; Targher et al. 2000). Several mecha-
nisms have been suggested to account for the
smoking-related increase in tHcy, including
changes in plasma thiol redox status, possibly
because of a higher formation of reactive oxy-
gen species; inactivation of the enzymes of
homocysteine remethylation, such as methion-
ine synthase; reduced intake of nutrients and
vitamins; and lower levels of plasma folate, vit-
amin B12, and plasma pyridoxal 5-phosphate
(De Bree et al. 2002).
Oxidative stress and endothelial dysfunc-
tion, which are enhanced in subjects with
hyperhomocysteinemia (De Bree et al. 2002),
have been associated with both cigarette smok-
ing (Targher et al. 2000) and exposure to air
particles (Brook et al. 2004; Utell et al. 2002).
It has been suggested that noncompensated
oxidative stress may contribute to the increase
in plasma homocysteine concentrations by
subtracting from the synthesis of homocys-
teine methyl group donors that are used to
compensate cell oxidative damage (Gori et al.
2005). It is possible that the inﬂammatory sta-
tus induced by cigarette smoking produces an
increased demand for methyl group donors
that may be exacerbated by air particle expo-
sure. Thus, smoking may amplify the effects
of PM10 on homocysteine metabolisms and
produce the association that we observed
among smokers. The results of previous inves-
tigations have shown that people with conges-
tive heart failure, conduction disorders,
myocardial infarction, chronic obstructive pul-
monary disorder, and diabetes are at greater
risk of adverse events associated with air pollu-
tion in general and speciﬁcally with particulate
matter (Bateson and Schwartz 2004). Smoking
Air pollution, smoking, and homocysteine
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Table 3. Estimates of the effect of IQR increase in air pollutants on fasting and postmethionine-load homo-
cysteine.
24-hr moving average 7-day moving average
Homocysteine differencea Homocysteine differencea
Pollutant IQR Percent (95% CI) Pollutant IQR Percent (95% CI)
Homocysteine, fastingb
PM10 32.5 0.4 (–2.4 to 3.3) 25.7 1.0 (–1.9 to 3.9)
CO 1.3 –0.8 (–3.7 to 2.2) 1.3 –2.4 (–5.6 to 0.8)
NO2 16.8 0.2 (–2.4 to 3.0) 16.3 –1.8 (–4.9 to 1.4)
SO2 17.1 0.1 (–4.1 to 4.4) 11.2 0.1 (–2.8 to 3.1)
O3 21.4 6.7 (0.9 to 12.8)* 21.6 4.5 (–1.9 to 11.3)
Homocysteine, postmethionine-loadb
PM10 32.5 1.1 (–1.5 to 3.7) 25.7 2.0 (–0.6 to 4.7)
CO 1.3 –0.4 (–3.0 to 2.3) 1.3 0.5 (–2.4 to 3.5)
NO2 16.8 0.0 (–2.4 to 2.4) 16.3 0.4 (–2.4 to 3.4)
SO2 17.1 1.7 (–2.1 to 5.6) 11.2 1.7 (–1.0 to 4.4)
O3 21.4 3.6 (–1.4 to 9.0) 21.6 –0.7 (–6.1 to 5.1)
aPercent difference in plasma homocysteine per IQR increase in air pollutant, adjusted for age, sex, BMI, cigarette smok-
ing, alcohol consumption, oral contraceptives, and penalized smoothing splines for day of the year (df = 4), long-term time
trend (df = 3), and temperature (df = 4). bTotal plasma homocysteine measured by high-performance liquid chromatogra-
phy after overnight fasting and 4 hr after an oral methionine loading (3.8 g/m2 of body surface area). *p < 0.05 for the asso-
ciation with pollutant levels.
Figure 2. Estimates of the effect on fasting homo-
cysteine of an IQR increase in the average concen-
tration of PM10 during the 24 hr before the study, by
cigarette smoking.
*p < 0.05.
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Table 2. Air pollution profile and weather variables in Lombardia Region, Italy, from 1 January 1995 to
1 September 2005.a
Percentile
No.b 25th Median 75th Maximum
Air pollutants
PM10 (µg/m3) 776,318 20.1 34.1 52.6 390.0
CO (ppm) 822,034 0.50 0.85 1.50 20.59
NO2 (ppb) 821,363 13.6 22.7 33.7 194.2
SO2 (µg/m3) 822,180 3.2 6.3 11.8 253.3
O3 (ppb) 810,509 7.0 18.3 35.1 202.3
Weather variables
Temperature (°C) –17.3 6.0 12.9 19.8 41.2
Barometric pressure (mmHg) 850.0 982.4 996.3 1005.0 1050.0
Relative humidity (%) 0.0 57.6 76.1 91.8 100.0
aAverage of hourly measurements from multiple monitors located in each of the nine pollution areas. Concentrations
were missing for the earlier periods of the study in some of the study areas (total possible hours, n = 841,536). bFor
weather variables, minimum.Baccarelli et al.
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is strongly associated with most of these
conditions and may represent the underlying
modifier determining the stronger air pollu-
tion effects observed in those high-risk groups.
Our estimates for the association of PM10
levels with increased tHcy among smokers
indicate that an IQR difference in PM10 aver-
age concentration in the preceding 24 hr is
associated with a 6.3% increase in fasting
tHcy and a 4.9% increase in PML tHcy
(Figure 2). The clinical significance of the
PM10-related increases in tHcy in our study is
uncertain and should also be interpreted in the
light of the results of recent large multicenter
clinical trials on homocysteine-lowering treat-
ment that failed to demonstrate a reduction in
major cardiovascular events in high-risk sub-
jects with previous acute myocardial infarction
(Lonn et al. 2006) or preexisting cardio-
vascular disease or diabetes (Bonaa et al.
2006). These results may suggest that differ-
ences in tHcy such as those observed in our
study may represent indicators of increased
cardiovascular risk, rather than causal determi-
nants of cardiovascular disease.
In our previous work on this same popula-
tion (Baccarelli et al. 2006), we found that
PM10 exposure was associated with shortened
prothrombin time, suggesting the presence of
exposure-related hypercoagulability in the
same subjects of this present study. However,
cigarette smoking did not modify the associa-
tion of prothrombin time with PM10 levels,
thus indicating that the interaction with
smoking could be operating through mecha-
nisms that are speciﬁc to the tHcy pathway.
In addition, we found a positive associa-
tion between O3 levels measured in the 24 hr
before the study and fasting tHcy. Short-term
exposure to O3, one of the most potent single
oxidants in the ambient air pollutant mixture,
has been associated with decreased heart rate
variability (Schwartz et al. 2005), ventricular
arrhythmia (Rich et al. 2005), ischemic heart
disease (Lee et al. 2003), and cardiovascular
mortality (Gryparis et al. 2004). O3 has been
shown to produce inﬂammatory reactions in
the respiratory tract (Aris et al. 1993; Balmes
et al. 1996), as well as systemic inﬂammation
and procoagulant status (Hermans et al.
2005). However, our results on the association
of O3 with tHcy did not show a consistent
pattern when we evaluated postload tHcy lev-
els and no signiﬁcant associations were found
when the 7-day average of O3 levels was used
in the analyses. 
A limitation of our study is that we used
ambient air pollution as a surrogate for per-
sonal exposure, which may have resulted in
measurement error. Such measurement error
would generally tend to bias estimates toward
the null (Samet et al. 2000a) and may have
contributed to the overall lack of association in
our study. However, a recent study comparing
personal exposures to site monitoring in
Boston, Massachusetts, reported that monitor
readings and personal exposure are highly cor-
related (Sarnat et al. 2005). Moreover, it has
been suggested that the consequence of using
ambient measures to estimate exposure is likely
to be only a modest underestimation of pollu-
tion effects (Zeger et al. 2000). Our study was
based on readings of hourly air pollution data
from 53 different monitoring sites throughout
Lombardia Region that were selected on the
basis of their capability to represent local back-
ground air pollution, as determined by correla-
tion with random in situ measurements in the
adjacent territory. The analysis was based on
the average concentrations in nine different
pollution areas, to which study subjects were
assigned based on their residence. The nine
areas showed spatially homogenous pollution
patterns, as determined by the high correlation
of the measures from the monitoring stations in
the same area, as well as of measurements per-
formed at different within-area locations during
the study period. In addition, we considered in
the analysis several potential confounding fac-
tors that may have inﬂuenced tHcy. Age, sex,
body mass index, alcohol consumption, hor-
mone use, day of the study, and temperature
did not confound the association between air
pollution and homocysteine. Therefore,
chances that the observed associations reﬂected
bias due to confounding factors are minimized. 
In conclusion, our study demonstrated no
consistent association of air pollution levels
with fasting and postmethionine load tHcy
when all subjects where considered. However,
we found increased tHcy levels in association
with higher concentrations of ambient PM10
amongsmokers, suggesting that cigarette smok-
ing and air pollution may interact in increasing
plasma tHcy levels in healthy subjects.
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